Edition:
India

Nuvectra Corp (NVTR.OQ)

NVTR.OQ on NASDAQ Stock Exchange Global Market

8.85USD
15 Dec 2017
Change (% chg)

$-0.12 (-1.34%)
Prev Close
$8.97
Open
$8.98
Day's High
$9.14
Day's Low
$8.75
Volume
17,803
Avg. Vol
13,920
52-wk High
$14.55
52-wk Low
$4.94

Select another date:

Thu, Nov 2 2017

BRIEF-Nuvectra reports Q3 loss per share $1.09

* Q3 revenue rose 102 percent to $7.6 million Source text for Eikon: Further company coverage:

BRIEF-Nuvectra corp files for mixed shelf of upto $100 mln

* Nuvectra Corp files for mixed shelf of upto $100 million - sec filing‍​ Source text : http://bit.ly/2hQeDbP Further company coverage:

BRIEF-Nuvectra corp says effective Aug. 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics - SEC filing

* Nuvectra Corp - effective august 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics, S.A - SEC filing

BRIEF-Nuvectra Q2 loss per share $1.07

* Q2 revenue rose 183 percent to $7.2 million Source text for Eikon: Further company coverage:

BRIEF-Nuvectra unit enters into business property lease agreement

* Nuvectra Corp - effective July 1, 2017, unit entered into a business property lease agreement with BMT Ann Arbor, Llc Source text: (http://bit.ly/2u7IQEO) Further company coverage:

BRIEF-Nuvectra enters second amendment to development agreement with Aleva Neurotherapeutics

* Nuvectra- effective june 19, co entered second amendment to development agreement with aleva neurotherapeutics, s.a to amend agreement dated jan 29, 2016

BRIEF-Nuvectra files regulatory submission with FDA for Algovita MRI-conditional approval

* Nuvectra files regulatory submission with fda for Algovita MRI-conditional approval

Select another date: